Emirates Health Services (EHS) has announced the availability of BYANNLI, developed by Johnson & Johnson, for patients with schizophrenia at Al Amal Psychiatric Hospital, one of its affiliated facilities. Al Amal Psychiatric Hospital is the first government hospital in the UAE to introduce this innovative…
This article was originally aggregated from the source listed below.
Read Full Article on Gulf Today – Latest News →